Warning letter
Badrivishal Chemicals & Pharmaceuticals: warning letter of Mar 6, 2017
FDA warning letter 511820
Key facts
| Reference number | 511820 |
|---|---|
| Company | Badrivishal Chemicals & Pharmaceuticals |
| Issue date | Mar 6, 2017 |
| Posted date | Mar 6, 2017 |
| Product type | Drugs |
| Country | 1 |
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: